The spirometer market in Middle East & Africa is expected to grow from US$ 46.57 million in 2022 to US$ 82.97 million by 2028. It is estimated to grow at a CAGR of 10.1% from 2022 to 2028.
Moreover, smoking, genetic factors, and infections are among the common factors responsible for respiratory diseases. Medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis, and lung cancer, are significant public health burdens. With the increasing prevalence of smoking in developing countries and the aging population in high-income countries, COPD prevalence is projected to rise over the next forty years. According to a study titled “Prevalence, incidence, morbidity, and mortality rates of COPD in Saudi Arabia,” over the period 1990-2019, the prevalence and incidence of COPD in Saudi Arabia have been increasing. In 2019, an estimated 434,560 people were suffering from COPD in Saudi Arabia, corresponding to an increase of 329.82% compared with the number of diagnosed people in 1990. The prevalence rate of COPD increased by 49%, from 1,381.26 cases per 100,000 in 1990 to 2,053.04 cases per 100,000 in 2019.
In addition, a new American Cancer Society study published in JAMA determined that although death rates for most common diseases declined, death rates from COPD have doubled. Deaths from heart disease dropped 68%, and deaths from stroke dropped 77%. On the contrary, COPD-related deaths jumped 101%, according to the report. Patients suffering from respiratory disorders commonly experience difficulty in breathing. Further, early detection and diagnosis can help treat respiratory disease patients. In such cases, spirometry is a crucial technology that assists in indulging in the severity of the infection and avoids misdiagnosis. Thus, the market is witnessing positive growth with the increasing incidence of such respiratory diseases.
A few key players dominating the Middle East & Africa spirometer market are Baxter International Inc.; COSMED Srl; Henry Schein, Inc.; ICU Medical Inc.; Teleflex Incorporated; and VYAIRE MEDICAL, INC.
Moreover, smoking, genetic factors, and infections are among the common factors responsible for respiratory diseases. Medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis, and lung cancer, are significant public health burdens. With the increasing prevalence of smoking in developing countries and the aging population in high-income countries, COPD prevalence is projected to rise over the next forty years. According to a study titled “Prevalence, incidence, morbidity, and mortality rates of COPD in Saudi Arabia,” over the period 1990-2019, the prevalence and incidence of COPD in Saudi Arabia have been increasing. In 2019, an estimated 434,560 people were suffering from COPD in Saudi Arabia, corresponding to an increase of 329.82% compared with the number of diagnosed people in 1990. The prevalence rate of COPD increased by 49%, from 1,381.26 cases per 100,000 in 1990 to 2,053.04 cases per 100,000 in 2019.
In addition, a new American Cancer Society study published in JAMA determined that although death rates for most common diseases declined, death rates from COPD have doubled. Deaths from heart disease dropped 68%, and deaths from stroke dropped 77%. On the contrary, COPD-related deaths jumped 101%, according to the report. Patients suffering from respiratory disorders commonly experience difficulty in breathing. Further, early detection and diagnosis can help treat respiratory disease patients. In such cases, spirometry is a crucial technology that assists in indulging in the severity of the infection and avoids misdiagnosis. Thus, the market is witnessing positive growth with the increasing incidence of such respiratory diseases.
Middle East & Africa Spirometer Market Segmentation
The Middle East & Africa spirometer market is segmented by type, technology, application, and country. Based on type, the market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. The table-top spirometers segment dominated the market in 2022. By technology, the market is segmented into volume, flow, and peak flow. The flow segment dominated the market in 2022. By application, the market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. The chronic obstructive pulmonary disease segment dominated the market in 2022. Based on country, the market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. Further, Saudi Arabia dominated the market in 2022.A few key players dominating the Middle East & Africa spirometer market are Baxter International Inc.; COSMED Srl; Henry Schein, Inc.; ICU Medical Inc.; Teleflex Incorporated; and VYAIRE MEDICAL, INC.
Table of Contents
1. Introduction
3. Research Methodology
4. MEA Spirometer Market - Market Landscape
5. MEA Spirometer Market - Key Market Dynamics
6. Spirometer Market- MEA Analysis
7. MEA Spirometer Market- by Type
8. MEA Spirometer Market - by Technology
9. MEA Spirometer Market- by Application
10. MEA Spirometer Market- Country Analysis
11. MEA Spirometers Market-Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Baxter International Inc.
- COSMED Srl
- Henry Schein, Inc.
- ICU Medical Inc.
- Teleflex Incorporated
- VYAIRE MEDICAL, INC.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 113 |
| Published | October 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 46.57 Million |
| Forecasted Market Value ( USD | $ 82.97 Million |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Africa, Middle East |
